The CCR5-Δ32 mutation: impact on disease outcome in individuals with hepatitis C infection From a single source

Goulding, C.; Murphy, A.; MacDonald, G.; Barrett, S.; Crowe, J.; Hegarty, J.; McKiernan, S.; Kelleher, D.
August 2005
Gut;Aug2005, Vol. 54 Issue 8, p1157
Academic Journal
Background and aims: Chemokines are small polypeptides, a major function of which is lymphocyte recruitment and trafficking. The aim of this study was to assess the involvement of inherited variations in CCR2, CCR5, and the ligand RANTES in determining disease outcome in hepatitis C virus (HCV) infected individuals. Methods: A total of 283 women, all exposed to HCV genotype 1b from a single donor, and including those who had spontaneously cleared the virus and those chronically infected, were genotyped for CCR2, CCR5, and RANTES polymorphisms. The frequencies of these polymorphisms were then compared with disease activity and severity. Results: CCR5, CCR2, and RANTES genotypes were compared with HCV polymerase chain reaction (PCR) status, alanine aminotransferase levels, and liver histology. There was no significant relationship between CCR2 or RANTES polymorphisms and disease outcome or severity. However, CCR5Δ32 heterozygotes were more likely to have spontaneous clearance of the virus than those without the mutation (42% PCR negative v 28.3% negative; p =0.044, odds ratio 1.83 (95% confidence interval 1.1-3.6)). Among the subgroup of DRB1 *03011 negative individuals, previously found to be associated with more severe inflammation, the difference in histological inflammatory score (CCR5WT/WT =4.9 v CCR5Δ32/ WT= 3.53; p=0.043) was significant. Conclusion: Heterozygosity for CCR5Δ32 was shown to be significantly associated with spontaneous hepatitis C viral clearance and with significantly lower hepatic inflammatory scores in subgroups within this cohort. Both controls and the HCV population had similar heterozygosity frequencies.


Related Articles

  • Nonresponder Patients with Hepatitis C Virus Genotype 2/3 Infection: A Question of Low Systemic Interferon Concentrations? Alsiö, Åsa; Christensen, Peer Brehm; Färkkilä, Martti; Langeland, Nina; Buhl, Mads Rauning; Pedersen, Court; Mørch, Kristine; Haagmans, Bart L.; Westin, Johan; Hellstrand, Kristoffer; Norkrans, Gunnar; Lagging, Martin // Clinical Infectious Diseases;2/15/2010, Vol. 50 Issue 4, pe22 

    Twelve of 303 per-protocol patients were nonresponders in a 12-week versus 24-week treatment study of hepatitis C virus (HCV) genotype 2/3 infection. The nonresponders had significantly lower interferon concentrations, as well as significantly greater mean age, body mass index, and viral load....

  • Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expression. Kaukinen, Pasi; Sillanpää, Maarit; Kotenko, Sergei; Lin, Rongtuan; Hiscott, John; Melén, Krister; Julkunen, Ilkka // Virology Journal;2006, Vol. 3, p66 

    Background: Hepatitis C virus (HCV) encodes several proteins that interfere with the host cell antiviral response. Previously, the serine protease NS3/4A was shown to inhibit IFN-β gene expression by blocking dsRNA-activated retinoic acid-inducible gene I (RIG-I) and Toll-like receptor 3...

  • Variants in the ITPA Gene Protect Against Ribavirin-Induced Hemolytic Anemia in HIV/HCV-Coinfected Patients With All HCV Genotypes. Naggie, Susanna; Rallon, Norma I.; Benito, José M.; Morello, Judith; Rodriguez-Novoa, Sonia; Clark, Paul J.; Thompson, Alexander J.; Shianna, Kevin V.; Vispo, Eugenia; McHutchison, John G.; Goldstein, David B.; Soriano, Vincent // Journal of Infectious Diseases;2/1/2012, Vol. 205 Issue 3, p376 

    Background. A recent genome-wide association study reported a strong association with a single-nucleotide polymorphism (SNP) in the inosine triphosphate (ITPA) gene and hemolytic anemia in patients infected with hepatitis C virus (HCV) receiving pegylated interferon and ribavirin. We investigate...

  • IL-28B Polymorphisms Correlated with Treatment Response in HCV-4 Mono-Infected Patients: A Meta-Analysis. Liu, Tonggang; Sha, Kaihui; Yang, Luhua; Wang, Yun; Zhang, Liguo; Liu, Xianxian; Yang, Fang // PLoS ONE;Mar2014, Vol. 9 Issue 3, p1 

    Background: The role of interleukin 28B (IL-28B) polymorphisms played in hepatitis C virus (HCV) infection has been gradually explicit, especially in HCV genotype 1, 2 and 3. However, no confirmative conclusion was acquired in genotype 4 HCV patients. Thus we conducted this meta-analysis....

  • Chemokine system polymorphisms, survival and hepatocellular carcinoma occurrence in patients with hepatitis C virus-related cirrhosis. Nahon, Pierre; Sutton, Angela; Rufat, Pierre; Simon, Chantal; Trinchet, Jean-Claude; Gattegno, Liliane; Beaugrand, Michel; Charnaux, Nathalie; Rodrigo, Luis; Shimada, Mitsuo; Einarsson, Curt // World Journal of Gastroenterology;2/7/2008, Vol. 14 Issue 5, p713 

    AIM: To explore the influence of polymorphisms in genes encoding for the chemokines Stromal cell-Derived Factor-1 (SDF-1)/CXCL12 and Monocyte Chemotactic Protein-1 (MCP-1) /CCL2, or for the chemokine receptor CCR5 on the risks of liver-related death and hepatocellular carcinoma (HCC) occurrence...

  • Host genetic determinants in hepatitis C virus infection. Yee, L.J. // Genes & Immunity;Jun2004, Vol. 5 Issue 4, p237 

    In addition to viral and environmental/behavioural factors, host genetic diversity is believed to contribute to the spectrum of clinical outcomes in hepatitis C virus (HCV) infection. This paper reviews the literature with respect to studies of host genetic determinants of HCV outcome and...

  • Rate of Sustained Virologic Response in Relation to Baseline Hepatitis C Virus (HCV) RNA Level and Rapid Virologic Clearance in Persons with Acute HCV Infection. McGovern, Barbara H.; Nagami, Ellen H.; Birch, Christopher E.; Bowen, Melinda J.; Reyor, Laura L.; Chung, Raymond T.; Kim, Arthur Y. // Journal of Infectious Diseases;9/15/2009, Vol. 200 Issue 6, p877 

    Treatment of acute hepatitis C virus (HCV) infection leads to a sustained virologic response (SVR) in the vast majority of patients, although the clinical predictors of these favorable responses are not well understood. In chronic infection, the most potent predictor of a SVR is complete viral...

  • Recombination in Hepatitis C Virus: Identification of Four Novel Naturally Occurring Inter-Subtype Recombinants. Shi, Weifeng; Freitas, Ines T.; Zhu, Chaodong; Zheng, Wei; Hall, William W.; Higgins, Desmond G. // PLoS ONE;Jul2012, Vol. 7 Issue 7, p1 

    Recombination in Hepatitis C virus (HCV) is considered to be rare. In this study, we performed a phylogenetic analysis of 1278 full-length HCV genome sequences to identify potential recombination events. Nine inter-genotype recombinants were identified, all of which have been previously...

  • Association of Transforming Growth Factor -- β1 Functional Polymorphisms with Natural Clearance of Hepatitis C Virus. Kimura, Tomomi; Saito, Takafumi; Yoshimura, Mika; Song Yixuan; Baba, Masanori; Guijin Ji; Muramatsu, Masaaki; Kawata, Sumio // Journal of Infectious Diseases;5/15/2006, Vol. 193 Issue 10, p1371 

    Transforming growth factor (TGF)-β1 suppresses the proliferation and cytotoxicity of natural killer (NK) cells, which play critical roles in resolving hepatitis C virus (HCV) infection, especially during the acute phase. We examined 230 anti-HCV antibody-positive subjects for HCV RNA and the...


Read the Article


Sign out of this library

Other Topics